The Human Microbiome: Advancing New Frontiers in a Rapidly Emerging Market

Feb 04, 2016, 18:19 ET from ReportBuyer

LONDON, Feb. 4, 2016 /PRNewswire/ -- The field of Human Microbiome research and development is apparently one of the most popular hubs of the biotechnology industry. While the Human Microbiome Project, MetaHIT and other huge studies of human microbiota, have garnered a lot of attention over that past few years, the microbiome space has literally exploded in terms of both basic and applied biomedical research.

This report focuses on biomedical aspects of research, development, and commercial endeavors in the human microbiome space. It includes essential background information, evolution of the field, advances in basic research, events in the emerging commercial market, deal activity, interviews with experts, and trends in microbiome research and commerce. Primary sources of information for this report include the scientific literature, discussions with experts, and an online survey of individuals working in this space.

This Report Covers:

Advances in Research on the Human Microbiome
Commercial Aspects of Microbiome Research and Development
Current Deal Activity
Over 25 Companies Profiled
Survey data from exclusive Insight Pharma Reports Survey

Interviews with:

Lee Jones, Founder CEO, Rebiotix
Brian Varnum, PhD, Chief Development Officer C3 Jian
Yanjiao Zhou, MD, PhD, Research Scientist, The Jackson Laboratory for Genomic Medicine
Dr Bernard Malfroy-Camine, President and CEO, ViThera Pharmaceuticals
Mark L. Heiman, Ph.D., FTOS, Vice President, Research and CSO, MicroBiome Therapeutics (formerly NuMe Health)
Larry Weiss, MD, Chief Medical Officer, AOBiome, LLC
Karen E. Nelson, PhD, President, J. Craig Venter Institute (JCVI), Head, Microbiome Program, Human Longevity Institute (HLI)
Sara Malcus, PhD, CEO, MetaboGen AB

Download the full report:

About Reportbuyer
Reportbuyer is a leading industry intelligence solution that provides all market research reports from top publishers

For more information:
Sarah Smith
Research Advisor at
Tel: +44 208 816 85 48

SOURCE ReportBuyer